Article Versions Notes

Hellmich MR, Chao C, Módis K, Ding Y, Zatarain JR, Thanki K, Maskey M, Druzhyna N, Untereiner AA, Ahmad A, et al. Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition Concept. Biomolecules. 2021; 11(8):1073. https://doi.org/10.3390/biom11081073

Hellmich, Mark R., Celia Chao, Katalin Módis, Ye Ding, John R. Zatarain, Ketan Thanki, Manjit Maskey, Nadiya Druzhyna, Ashley A. Untereiner, Akbar Ahmad, and et al. 2021. "Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition Concept" Biomolecules 11, no. 8: 1073. https://doi.org/10.3390/biom11081073

Hellmich, M. R., Chao, C., Módis, K., Ding, Y., Zatarain, J. R., Thanki, K., Maskey, M., Druzhyna, N., Untereiner, A. A., Ahmad, A., Xue, Y., Chen, H., Russell, W. K., Wang, J., Zhou, J., & Szabo, C. (2021). Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition Concept. Biomolecules, 11(8), 1073. https://doi.org/10.3390/biom11081073